MarketPeel
Insider Trading Intelligence
HL

Hhlr Advisors, Ltd.

AVBP
10% OWNER · ARRIVENT BIOPHARMA, INC. · CIK 0001762304
FILING MIX · LIFETIME50%/50%
BUYS
3
SELLS
3
TOTAL VALUE
$22.98M
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
3,929,117
AVG SELL PX
$23.37
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Hhlr Advisors, Ltd., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%-4.33%-0.86%-3.47%-3.47%
14d2+50.00%-4.46%+0.53%-4.99%-4.99%
30d2+50.00%-8.91%+2.22%-11.13%-11.13%
60d2+50.00%-15.49%+3.91%-19.39%-19.39%
90d2+0.00%-10.85%+1.36%-12.21%-12.21%
180d2+0.00%+11.59%+9.46%+2.13%+2.13%
1y2(1 pending)+100.00%+31.91%+24.17%+7.74%+7.74%
2y2(1 pending)+100.00%+2.27%+43.63%-41.35%-41.35%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVBP · 3,929,117 shares · as of Dec 10, 2025
01,121,1682,242,3363,363,5044,484,6722025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 3 buys / 3 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
555,555$23.37$12.98M3,929,117Dec 10, 2025Feb 3, 2026View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
555,555$18.00$10.00M4,484,672Jan 30, 2024Feb 1, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
4,761,9030Jan 30, 2024Feb 1, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
313,0763,929,117Jan 30, 2024Feb 1, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
3,616,0413,616,041Jan 30, 2024Feb 1, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
55,000,0000Jan 30, 2024Feb 1, 2024View →
Other insiders · AVBP
Loading peer insiders…
About this filer
CIK 0001762304
ROLE
10% Owner
PRIMARY
AVBP
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0001762304DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback